TrialDrug design, development and therapy2017

New tablet formulation of tacrolimus with smaller interindividual variability may become a better treatment option than the conventional capsule formulation in organ transplant patients.

Yu Kyong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.